Candida Glabrata

Common Name(s)

Candida Glabrata

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Candida Glabrata" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Candida Glabrata" returned 198 free, full-text research articles on human participants. First 3 results:

Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.
 

Author(s): Shoko Merrit Yamada, Yusuke Tomita, Tomotsugu Yamaguchi, Toshiaki Matsuki

Journal:

 

Micafungin and caspofungin, which are both echinocandins, elicit their antifungal effects by suppressing the synthesis of β-D-glucan, an essential component of fungal cell walls. If micafungin is not effective against a fungal infection, is it unreasonable to switch to caspofungin?

Last Updated: 8 Nov 2016

Go To URL
Rapid Detection of FKS-Associated Echinocandin Resistance in Candida glabrata.
 

Author(s): Yanan Zhao, Yoji Nagasaki, Milena Kordalewska, Ellen G Press, Ryan K Shields, M Hong Nguyen, Cornelius J Clancy, David S Perlin

Journal:

 

A novel and highly accurate diagnostic assay platform was established for rapid identification of FKS mutations associated with echinocandin resistance in Candida glabrata The assay platform uses allele-specific molecular beacon and DNA melt analysis following asymmetric PCR. A dual ...

Last Updated: 23 Aug 2016

Go To URL
Heteroresistance to Fluconazole Is a Continuously Distributed Phenotype among Candida glabrata Clinical Strains Associated with In Vivo Persistence.
 

Author(s): Ronen Ben-Ami, Offer Zimmerman, Talya Finn, Sharon Amit, Anna Novikov, Noa Wertheimer, Mor Lurie-Weinberger, Judith Berman

Journal:

 

Candida glabrata causes persistent infections in patients treated with fluconazole and often acquires resistance following exposure to the drug. Here we found that clinical strains of C. glabrata exhibit cell-to-cell variation in drug response (heteroresistance). We used population ...

Last Updated: 3 Aug 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Candida Glabrata" returned 7 free, full-text review articles on human participants. First 3 results:

Candida glabrata: new tools and technologies-expanding the toolkit.
 

Author(s): Hsueh-lui Ho, Ken Haynes

Journal: FEMS Yeast Res.. 2015 Sep;15(6):.

 

In recent years, there has been a noticeable rise in fungal infections related to non-albicans Candida species, including Candida glabrata which has both intrinsic resistance to and commonly acquired resistance to azole antifungals. Phylogenetically, C. glabrata is more closely related ...

Last Updated: 18 Aug 2015

Go To URL
Candida glabrata: a deadly companion?
 

Author(s): Monique Bolotin-Fukuhara, Cécile Fairhead

Journal: Yeast. 2014 Aug;31(8):279-88.

 

The yeast Candida glabrata has become a major fungal opportunistic pathogen of humans since the 1980s. Contrary to what its name suggests, it is much closer, phylogenetically, to the model yeast Saccharomyces cerevisiae than to the most prevalent human fungal pathogen, Candida albicans. ...

Last Updated: 18 Aug 2014

Go To URL
Arteriovenous graft infection caused by Candida glabrata: A case report and literature review.
 

Author(s): Hung-Ling Huang, Chun-Yu Lin, Ya-Ting Chang, Yen-Hsu Chen, Wei-Tsung Wu, Po-Liang Lu

Journal: J Microbiol Immunol Infect. 2016 Apr;49(2):300-4.

 

The infection rate of arteriovenous (AV) grafts is high, but fungal etiology is rare. Only five cases of graft infection due to Candida albicans (C. albicans) or C. tropicalis have been described in the literature. Herein, we report the first case of AV graft infection caused by C. ...

Last Updated: 26 Mar 2016

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

There are currently no open clinical trials for this condition.